Furthermore, other reports show no protective effect of monotherapy in models of quickly progressing B16-F1 mouse melanoma tumors through lack of clonal expansion and effector functions of antigen-specific CD8+ T cells (26, 52–55). The gene discussed is CD8A; the disease is melanoma.